Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial

PURPOSE: The Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) trial established perioperative epirubicin, cisplatin, and fluorouracil chemotherapy as a standard of care for patients with resectable esophagogastric cancer. However, identification of patients at risk for relap...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Autores principales: Smyth, Elizabeth C., Fassan, Matteo, Cunningham, David, Allum, William H., Okines, Alicia F.C., Lampis, Andrea, Hahne, Jens C., Rugge, Massimo, Peckitt, Clare, Nankivell, Matthew, Langley, Ruth, Ghidini, Michele, Braconi, Chiara, Wotherspoon, Andrew, Grabsch, Heike I., Valeri, Nicola
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2016
Materias:
ORIGINAL REPORTS
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5019747/
https://ncbi.nlm.nih.gov/pubmed/27298411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.65.7692
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares